Source comparison
Comparison Table: CJC-1295 no DAC & Ipamorelin Monthly Budget by Protocol Type
| Protocol Intensity | Injections/Week | Monthly Peptide Cost | Monthly Ancillary Cost | Total Monthly Budget | Peptide Stability Consideration | Professional Assessment ||—|—|—|—|—|—|| Conservative (3x weekly, 100mcg + 200mcg) | 3 | $45–$65 | $25–$35 | $70–$1
This comparison does not assign a generated winner or score.
- | Protocol Intensity | Injections/Week | Monthly Peptide Cost | Monthly Ancillary Cost | Total Monthly Budget | Peptide Stability Consideration | Professional Assessment ||—|—|—|—|—|—|| Conservative (3x weekly, 100mcg + 200mcg) | 3 | $45–$65 | $25–$35 | $70–$100 | Lyophilized vials last 4 months. Minimal waste | Best cost-efficiency for exploratory research with flexible timelines || Standard (5x weekly, 100mcg + 200mcg) | 5 | $60–$85 | $30–$45 | $90–$130 | Single vial pair covers 2.5 months. Moderate waste risk if protocol interrupted | Optimal balance between dosing density and budget sustainability || Intensive (7x daily, 100mcg + 200mcg) | 7 | $120–$185 | $35–$50 | $155–$235 | Requires multiple vials monthly. Higher waste if reconstitution timing misaligned | Only justified when frequent pulsatile GH elevation is the primary research variable || High-Dose Standard (5x weekly, 200mcg + 300mcg) | 5 | $120–$170 | $35–$50 | $155–$220 | Burns through vials in <6 weeks. Frequent reorderi